KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Resmed (RMD) Invested Capital (2016 - 2025)

Resmed (RMD) has disclosed Invested Capital for 16 consecutive years, with $6.7 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Invested Capital rose 13.67% year-over-year to $6.7 billion, compared with a TTM value of $6.7 billion through Dec 2025, up 13.67%, and an annual FY2025 reading of $6.6 billion, up 19.15% over the prior year.
  • Invested Capital was $6.7 billion for Q4 2025 at Resmed, up from $6.5 billion in the prior quarter.
  • Across five years, Invested Capital topped out at $6.7 billion in Q4 2025 and bottomed at $3.4 billion in Q1 2021.
  • Average Invested Capital over 5 years is $5.2 billion, with a median of $5.6 billion recorded in 2023.
  • The sharpest move saw Invested Capital dropped 5.33% in 2021, then surged 44.97% in 2022.
  • Year by year, Invested Capital stood at $3.8 billion in 2021, then soared by 44.97% to $5.5 billion in 2022, then grew by 3.07% to $5.7 billion in 2023, then increased by 3.81% to $5.9 billion in 2024, then increased by 13.67% to $6.7 billion in 2025.
  • Business Quant data shows Invested Capital for RMD at $6.7 billion in Q4 2025, $6.5 billion in Q3 2025, and $6.6 billion in Q2 2025.